The disclosure provides methods for the use of gene expression measurements to classify or identify neuroendocrine cancer in samples obtained from a subject in a clinical setting, such as in cases of formalin fixed, paraffin embedded (FFPE) samples.
申请公布号
WO2014160645(A2)
申请公布日期
2014.10.02
申请号
WO2014US31587
申请日期
2014.03.24
申请人
BIOTHERANOSTICS, INC.;SCHNABEL, CATHERINE, A.;ZHANG, YI;ERLANDER, MARK, G.
发明人
SCHNABEL, CATHERINE, A.;ZHANG, YI;ERLANDER, MARK, G.
